Pediatria Polska

Abstract

4/2025 vol. 100
Case report

15q13.2q13.3 microdeletion syndrome with congenital stationary night blindness due to compound deletion and a missense point mutation in TRPM1 gene

  1. Department of Medical Genetics, The Children’s Memorial Health Institute, Warszawa, Poland
  2. Department of Ophthalmology, Professor Jan Bogdanowicz Children’s Hospital, Warszawa, Poland
  3. Warsaw Genomics, Warszawa, Poland
ediatr Pol 2025; 100 (4): 394 -397
Online publish date: 2025/11/19
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
The 15q13.3 microdeletion syndrome is associated with a variable phenotype, often with incomplete penetrance, characterised by psychomotor developmental delay, intellectual disability, autism spectrum disorders, and nonspecific dysmorphic features. Epilepsy, congenital heart defects, and ophthalmologic abnormalities, including strabismus and/or astigmatism, may also occur. In the case of a homozygous 15q13.3 deletion involving the TRPM1 gene, symptoms of congenital stationary night blindness additionally appear. A similar clinical effect is associated with compound damage to both copies of the TRPM1 gene, in the form of a deletion involving this gene on one allele and a point mutation in TRPM1 on the other allele. We present a patient with a complex 15q13.2q13.3 deletion and a hemizygous TRPM1 variant c.332A>G, p.Tyr111Cys, in whom neurodevelopmental symptoms coexist with congenital stationary night blindness.
Share
without publication fees
without publication fees